Fresh analysis reveals that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who end traditional diet and exercise plans.
Findings released in a leading medical journal points out that while obese people often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Users buying these treatments need to be cognizant of the potential of fast rebound weight gain when the medication concludes," warns researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight in about 18 months.
Comparing Approaches
The research, which examined 37 of trials involving thousands of participants, contrasted the effects of these new drugs with conventional dieting.
Scientists note that individuals who shed pounds through lifestyle changes alone generally see a more gradual creep back—around 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Doctors suggest the mechanism of the jabs explains the heightened regain.
These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating much more probable."
A Lifelong Disease?
Health authorities advise the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, due to the high risk of weight regain, the treatment is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the chronic character of excess weight," similar to managing conditions like hypertension.
User Accounts
Users who have come off the medication explain a powerful return of cravings.
"It felt as if a trigger that goes on and you're instantly extremely hungry," described an individual.
The struggle is worsened if users have not established lasting lifestyle or habit changes during therapy.
Significant Interest
Survey data show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is higher among women than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a standalone fix and long-term success relies on integrated lifestyle management.
